All Posts
Link between fluoroquinolones, aorta problems may not be as strong as thought
10 Sep, 2020 | 09:31h | UTCLink between fluoroquinolones, aorta problems may not be as strong as thought – CIDRAP
Original Studies: Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection – JAMA Internal Medicine AND Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection
Overtraining syndrome: what it is and how to avoid it
10 Sep, 2020 | 09:28h | UTCOvertraining syndrome: what it is and how to avoid it – The Conversation
Welcoming new guidelines for AI clinical research
10 Sep, 2020 | 09:23h | UTCWelcoming new guidelines for AI clinical research – Nature Medicine
Guidelines: Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension – Nature Medicine AND Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension – Nature Medicine
Commentary on Twitter
Today's a very big day fo #AI medical research
There are major publications of consensus statements and guidelines published @NatureMedicine @LancetDigitalH @bmj_latest on protocols, trial design, and reporting
Here's my commentary @NatureMedicine https://t.co/86b8WxjX0Q pic.twitter.com/PwYPF7o4qn— Eric Topol (@EricTopol) September 9, 2020
WHO calls for global action on sepsis – cause of 1 in 5 deaths worldwide
10 Sep, 2020 | 09:27h | UTCWHO calls for global action on sepsis – cause of 1 in 5 deaths worldwide – World Health Organization
Report: Global report on the epidemiology and burden of sepsis – World Health Organization
Commentary on Twitter
Today the first Global report on #sepsis was launched, offering the most comprehensive evidence on the life-threatening condition
👉 https://t.co/sSLSPAQFv8 pic.twitter.com/iCv4n2Ux9n
— World Health Organization (WHO) (@WHO) September 9, 2020
Interactive calculator for interpreting Covid-19 antibody test results
9 Sep, 2020 | 09:12h | UTCTesting for SARS-CoV-2 antibodies – The BMJ
Commentary on Twitter
#BMJInfographic Try out this new interactive calculator for interpreting covid-19 antibody test results @will_s_t https://t.co/t0Ha5zMlg1 pic.twitter.com/TAjVLog3A1
— The BMJ (@bmj_latest) September 8, 2020
WHO: More than 3 billion people protected from harmful trans-fat in their food
10 Sep, 2020 | 09:25h | UTCReport: Countdown to 2023: WHO report on global trans-fat elimination 2020 – World Health Organization
Commentary on Twitter
More than 3⃣ billion people across 5⃣8⃣ countries are now protected from harmful trans-fat in their food since the launch of WHO’s global #REPLACEtransfat initiative.
More details 👉https://t.co/3E5NIo8Y9Z #BeatNCDs pic.twitter.com/OHevkpBgaj
— World Health Organization (WHO) (@WHO) September 9, 2020
Opinion: “Facial masking for Covid-19 — potential for “variolation” as we await a vaccine”
9 Sep, 2020 | 09:39h | UTC
Commentary on Twitter
Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths. #COVID19 #SARSCoV2
— NEJM (@NEJM) September 8, 2020
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
9 Sep, 2020 | 09:45h | UTC
Commentary on Twitter
BREAKING: AstraZeneca's #Covid19 vaccine trials have been paused as the company investigates a serious adverse event the occurred in the UK. Not clear if the unexplained illness is linked to the vaccine, or what it was. https://t.co/wGqvvXIBTD
— Helen Branswell 🇨🇦 (@HelenBranswell) September 8, 2020
Drug companies seek to reassure the public about Covid-19 vaccine safety
9 Sep, 2020 | 09:43h | UTCSee also: 9 Drugmakers Sign Safety Pledge In Rush To Develop Coronavirus Vaccine – NPR AND U.S., European COVID-19 vaccine developers pledge to uphold testing rigour – Reuters
[Preprint] Randomized trial: Convalescent plasma not associated with improved outcomes in Covid-19
9 Sep, 2020 | 09:41h | UTC
Commentary on Twitter
Convalescent Plasma Randomized Controlled Trial (PLACID Trial) in the Management of Moderate #COVID19 (pre-print)
👉 “not associated with reduction in mortality or progression to severe COVID-19”
Link: https://t.co/2ZXnfemsas@GermHunterMD @MackayIM @CT_Bergstrom #IDTwitter pic.twitter.com/yZuOxVhbjL
— Alvin (@alvie_barr) September 8, 2020
The coronavirus is mutating — does it matter?
9 Sep, 2020 | 09:35h | UTCThe coronavirus is mutating — does it matter? – Nature
The immunology of multisystem inflammatory syndrome in children with COVID-19
9 Sep, 2020 | 09:33h | UTCThe Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 – Cell
Review: Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19
9 Sep, 2020 | 09:30h | UTC
IDSA Guidance on the treatment of antimicrobial resistant gram-negative infections
9 Sep, 2020 | 09:24h | UTCNews Release: IDSA Releases Guidance On Treatment Of Antimicrobial-Resistant Infections
Commentary on Twitter
The new @IDSAInfo guidance document on the treatment of MDR GN infections is 🔥🔥🔥. This a really practical/pragmatic document and will be of great use to frontline clinicianshttps://t.co/Eoz2vEHppb
— Mike Stevens (@Dr_Mike_Stevens) September 8, 2020
IDSA Podcast: The global health impact of COVID-19
9 Sep, 2020 | 09:26h | UTCThe Global Health Impact of COVID-19 – Infectious Diseases Society of America
Commentary on Twitter
NEW PODCAST 🎙️ "The Global Health Impact of COVID-19"
Listen: https://t.co/Su7sJNq8CZ @CDCgov global health experts Dr. Barbara Marston & Dr. Nancy Knight join us to discuss the agency’s role in responding to the COVID-19 pandemic globally. @CDCGlobal pic.twitter.com/NowVQ301xU
— IDSA (@IDSAInfo) September 8, 2020
Perspective: “When will WE have a vaccine?” — understanding questions and answers about Covid-19 vaccination
9 Sep, 2020 | 09:37h | UTC
Commentary on Twitter
People inquiring about Covid-19 vaccines often want to know when the public can be confident that available vaccines are safe and effective, when a vaccine will be available to people like them, and when uptake will be high enough to enable a return to prepandemic life. #COVID19
— NEJM (@NEJM) September 8, 2020
Guidelines for the management of intravascular catheters in the ICU
9 Sep, 2020 | 09:22h | UTC
Randomized trial: Out-of-hospital tranexamic acid does not improve neurologic outcomes in patients with traumatic brain injury
9 Sep, 2020 | 09:20h | UTCEditorial: Out-of-Hospital Tranexamic Acid for Traumatic Brain Injury
Commentary on Twitter
In this phase II RCT prehospital tranexamic acid, which inhibits breakdown of fibrin clot, did not improve neurologic outcomes at 6 months vs placebo in patients with moderate to severe TBI https://t.co/PHK91YYxK3 @SusanRowellMD
— JAMA (@JAMA_current) September 8, 2020
Podcast: Update on bariatric surgery—2020
9 Sep, 2020 | 09:18h | UTCAudio Clinical Review: Update on Bariatric Surgery—2020 – JAMA
APA Guideline for the treatment of patients with schizophrenia
9 Sep, 2020 | 09:17h | UTC
#ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis
9 Sep, 2020 | 09:14h | UTCPhase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis – New England Journal of Medicine
Commentary on Twitter
Original Article: Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (WILLOW Trial) #ERScongress
— NEJM (@NEJM) September 7, 2020
#ERScongress – [Abstract Only] Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis
9 Sep, 2020 | 09:16h | UTC
Commentary on Twitter
Original Article: Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (IMPALA Trial) #ERScongress
— NEJM (@NEJM) September 7, 2020
Perspective – Let’s get real. No vaccine will work as if by magic, returning us to ‘normal’
8 Sep, 2020 | 01:22h | UTCLet’s get real. No vaccine will work as if by magic, returning us to ‘normal’ – The Guardian
WHO: Emergency use approval is a “temporary solution,” countries should wait for large clinical trials to finish to roll out a COVID-19 vaccine en masse
8 Sep, 2020 | 01:21h | UTC
An ethical framework for global vaccine allocation
8 Sep, 2020 | 01:24h | UTCAn ethical framework for global vaccine allocation – Science
Commentary: Who should get the COVID-19 vaccine first? – University of Pennsylvania School of Medicine
Commentaries on Twitter
How would #COVID19 vaccines be distributed fairly across the globe once they are made available? Prominent philosophers and bioethicists outline the "Fair Priority Model", a 3-phase plan for vaccine distribution in @ScienceMagazine. https://t.co/1gdErzkRRh
— Stanford Ethics (@StanfordEthics) September 7, 2020
A new, three-phase plan for vaccine distribution for #COVID19—called the Fair Priority Model—is “the best embodiment of the ethical values of limiting harms…and recognizing equal concern for all people,” argues this #SciMagPolicyForum. Learn more: https://t.co/WKMvqKgDjl
— Science Magazine (@ScienceMagazine) September 7, 2020